文献速递艾滋病与性传播感染

体液与先天抗病毒免疫作为清除持续性HIV感染的工具

Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection.
PubMed 文献 · J Infect Dis · 2017-01-01

本文综述了HIV-1潜伏感染CD4+ T细胞的机制,以及利用HIV-1 Env特异性抗体招募细胞毒性效应细胞(如自然杀伤细胞、单核细胞和多形核细胞)来消除潜伏感染细胞库的研究方向。

要点

  • HIV-1整合入宿主基因组,可在潜伏感染的CD4+ T细胞中保持转录沉默。
  • 潜伏原病毒再激活后,Env糖蛋白在细胞表面表达,使感染细胞可被免疫应答识别。
  • Env特异性抗体可结合细胞表面Env,招募细胞毒性效应细胞清除感染细胞。

核心结论

  • 利用体液和先天细胞免疫应答招募并重定向细胞毒性效应细胞,是消除HIV-1潜伏感染CD4+ T细胞库的创新策略方向。

研究设计与样本

  • 本文为综述,围绕HIV-1潜伏感染机制及体液与先天抗病毒免疫策略进行论述。

主要发现

  • HIV-1以CD4分子为主要受体感染T细胞,并将病毒基因组整合入宿主细胞导致持续性感染。
  • 潜伏感染的CD4+ T细胞中HIV-1可保持转录沉默,再激活后Env在细胞表面表达。
  • HIV-1 Env特异性抗体可结合细胞表面Env,通过招募自然杀伤细胞、单核细胞和多形核细胞等细胞毒性效应细胞促进感染细胞清除。

临床怎么用

  • 提示可探索Env特异性抗体联合细胞毒性效应细胞招募策略,以靶向清除HIV-1潜伏感染细胞库。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Human immunodeficiency virus (HIV) type 1 uses the CD4 molecule as its principal receptor to infect T cells. HIV-1 integrates its viral genome into the host cell, leading to persistent infection wherein HIV-1 can remain transcriptionally silent in latently infected CD4+ T cells. On reactivation of replication-competent provirus, HIV-1 envelope glycoproteins (Env) are expressed and accumulate on the cell surface, allowing infected cells to be detected and targeted by endogenous immune responses or immune interventions. HIV-1 Env-specific antibodies have the potential to bind HIV-1 cell surface Env and promote elimination of infected CD4+ T cells by recruiting cytotoxic effector cells, such as natural killer cells, monocytes, and polymorphonuclear cells. Harnessing humoral and innate cellular responses has become one focus of research to develop innovative strategies to recruit and redirect cytotoxic effector cells to eliminate the HIV-1 latently infected CD4+ T-cell reservoir.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Ferrari G, Pollara J, Tomaras GD, et al. Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection. J Infect Dis. 2017. PMID: 28520963. doi:10.1093/infdis/jiw555

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。